Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2030
The global market for Commercial Biotechnology Separation Systems estimated at US$24.6 Billion in the year 2022, is projected to reach a revised size of US$31 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2022-2030. Conventional, one of the segments analyzed in the report, is projected to record 2.7% CAGR and reach US$19 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Modern segment is readjusted to a revised 3.3% CAGR for the next 8-year period.The U.S. Market is Estimated at $6.7 Billion, While China is Forecast to Grow at 4.8% CAGR
The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.7 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$6 Billion by the year 2030 trailing a CAGR of 4.8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 2.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2% CAGR.Select Competitors (Total 46 Featured) -
- 3M Company
- AB Sciex
- Agilent Technologies, Inc.
- Alfa Laval AB
- Alfa Wassermann Separation Technologies LLC
- Beckman Coulter Inc.
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- Flottweg SE
- Fluidigm Corporation
- GE Healthcare
- Hitachi High-Technologies Corp.
- Illumina Inc.
- Merck KGaA
- Pall Corporation
- PerkinElmer Inc.
- ProMetic Life Sciences Inc.
- Repligen Corporation
- Sartorius Stedim Biotech SA
- Shimadzu Scientific Instruments
- Sysmex Partec GmbH
- Thermo Fischer Scientific Inc.
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Company
- AB Sciex
- Agilent Technologies, Inc.
- Alfa Laval AB
- Alfa Wassermann Separation Technologies LLC
- Beckman Coulter Inc.
- Becton Dickinson and Company
- Bio-Rad Laboratories Inc.
- Flottweg SE
- Fluidigm Corporation
- GE Healthcare
- Hitachi High-Technologies Corp.
- Illumina Inc.
- Merck KGaA
- Pall Corporation
- PerkinElmer Inc.
- ProMetic Life Sciences Inc.
- Repligen Corporation
- Sartorius Stedim Biotech SA
- Shimadzu Scientific Instruments
- Sysmex Partec GmbH
- Thermo Fischer Scientific Inc.
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 273 |
Published | April 2024 |
Forecast Period | 2022 - 2030 |
Estimated Market Value ( USD | $ 24.6 Billion |
Forecasted Market Value ( USD | $ 31 Billion |
Compound Annual Growth Rate | 2.9% |
Regions Covered | Global |